Tech Center 1600 • Art Units: 1617 1622 1627
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18280396 | TRICYCLIC PESTICIDAL COMPOUNDS | Non-Final OA | BASF SE |
| 18101220 | ANTIFUNGAL PROPHYLAXIS FOR CORNEA | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18468258 | NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18497296 | 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS | Non-Final OA | NOVARTIS AG |
| 18553411 | COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1P1), IMAGING OF S1P1, AND PROCESSES FOR PREPARATION THEREOF | Non-Final OA | Washington University |
| 18272022 | FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) | Non-Final OA | Vifor (International) AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy